Marginal Zone B-Cell Lymphoma

Extranodal lymphoma of lymphoid tissue associated with mucosa that is in contact with exogenous antigens. Many of the sites of these lymphomas, such as the stomach, salivary gland, and thyroid, are normally devoid of lymphoid tissue. They acquire mucosa-associated lymphoid tissue (MALT) type as a result of an immunologically mediated disorder.

Also Known As:

MALT Lymphoma; Lymphoma, Mucosa Associated Lymphoid Tissue; Lymphoma, MALT; Lymphoma, B-Cell, Marginal Zone; Lymphoma of Mucosa-Associated Lymphoid Tissue; Mucosa-Associated Lymphoid Tissue Lymphoma; Lymphoma of Mucosa Associated Lymphoid Tissue; Lymphomas, MALT; MALT Lymphomas; Marginal Zone B Cell Lymphoma; Mucosa Associated Lymphoid Tissue Lymphoma; Lymphoma, Mucosa-Associated Lymphoid Tissue

Neoplasms: 1324753
- Neoplasms by Histologic Type: 2
  - Lymphoma: 47916
    - Non-Hodgkin Lymphoma: 14954
      - B-Cell Lymphoma: 11416
        Marginal Zone B-Cell Lymphoma: 1670
Hemic and Lymphatic Diseases: 6
- Lymphatic Diseases: 92
  - Lymphoproliferative Disorders: 4250
    - Lymphoma: 47916
      - Non-Hodgkin Lymphoma: 14954
        B-Cell Lymphoma: 11416
        Marginal Zone B-Cell Lymphoma: 1670
Immune System Diseases: 4321
- Immunoproliferative Disorders: 29
  - Lymphoproliferative Disorders: 4250
    - Lymphoma: 47916
      - Non-Hodgkin Lymphoma: 14954
        B-Cell Lymphoma: 11416
        Marginal Zone B-Cell Lymphoma: 1670

Ariadna Torner Selected Research

Ariadna Torner Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure